BN 80927: a novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II
- Bioorg Med Chem Lett. 1999 Sep 6;9(17):2599-602. doi: 10.1016/s0960-894x(99)00428-x.
Affiliations
- 1. Institut Henri Beaufour, Les Ulis, France.
PMID: 10498216
DOI: 10.1016/s0960-894x(99)00428-x
Abstract
BN 80927, a novel homocamptothecin derivative, inhibits both Topoisomerase I and Topoisomerase II mediated DNA relaxation and shows pronounced cytotoxicity against HT29, SKOV-3, DU145 and MCF7 human tumor cell lines.